Quantcast

Latest Paul O'Connor Stories

2011-10-06 10:58:34

The drug also increased the length of time before a patient relapsed and more patients taking it remained free of relapses A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease. The results of the Phase 3 trial of the drug teriflunomide were published in The New England Journal of Medicine on Thursday. "This could be a safe, effective and convenient...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related